Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ALKBH5-IN-5 is an inhibitor of the mRNA N6-methyladenosine (m6A) demethylase activity of alpha-ketoglutarate-dependent dioxygenase alkB homolog 5 (ALKBH5; IC50 = 0.62 µM.1 It is selective for ALKBH5 over the m6A demethylase fat mass and obesity-associated protein (FTO) at 50 µM and a panel of 14 proteases at 10 µM. ALKBH5-IN-5 increases m6A levels in NB4 leukemia cells and reduces the proliferation of MOLM-13, MV4-11, NOMO-1, and NB4 leukemia cells (IC50s = 0.63-2.99 µM). It reduces tumor volume in an NB4 mouse xenograft model and inhibits tumor growth and metastasis in a 143B osteosarcoma mouse xenograft model overexpressing the long non-coding RNA (lncRNA) ZMIZ1-AS1, an effect that is enhanced when co-administered with the FGFR inhibitor BGJ398 (Item No. 19157).1,2
WARNING This product is not for human or veterinary use.
1. Discovery of covalent and cell-
2. ALKBH5 demethylation modification of SE-